Homestead Advisers’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.9M Buy
15,300
+2,800
+22% +$415K 0.07% 87
2026
Q1
$1.16M Hold
12,500
0.03% 105
2025
Q4
$1M Sell
12,500
-21,700
-63% -$1.82M 0.03% 106
2025
Q3
$3.34M Hold
34,200
0.08% 78
2025
Q2
$2.38M Hold
34,200
0.06% 90
2025
Q1
$1.7M Buy
34,200
+4,600
+16% +$291K 0.04% 91
2024
Q4
$2.07M Hold
29,600
0.05% 94
2024
Q3
$3.1M Hold
29,600
0.07% 86
2024
Q2
$4.21M Buy
29,600
+18,600
+169% +$2.14M 0.1% 72
2024
Q1
$1.23M Buy
+11,000
New +$1.31M 0.03% 97

Other funds holding ACLS

Homestead Advisers's ACLS Position: Q2 2026 in Review

Homestead Advisers increased its Axcelis (ACLS) stake by 22% in Q2 2026, buying an estimated $415K and bringing the position to 15,300 shares worth $2.9M. The position accounts for 0.07% of the portfolio, ranked #87.

Homestead Advisers first reported a position in ACLS in Q1 2024 and has held it in 10 quarters since. The position peaked at $4.21M in Q2 2024. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Homestead Advisers held 15,300 shares of Axcelis worth $2.9M as of Q2 2026.
  • Homestead Advisers bought 2,800 Axcelis shares in Q2 2026, an estimated $415K.
  • Axcelis made up 0.07% of Homestead Advisers's portfolio in Q2 2026, its #87 holding.
  • Homestead Advisers first reported a position in Axcelis in Q1 2024 and has held it in 10 quarters since.
  • Homestead Advisers's Axcelis position peaked at $4.21M in Q2 2024.
  • 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Homestead Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.